SYK
Stryker CorporationNYSEHealthcare$331.54+0.65%OpenMarket Cap: $126.88B
As of 2026-04-06
Valuation
P/E (TTM)
39.09
PEG
4.62
P/B
5.66
P/S
5.05
EV/EBITDA
24.66
DCF Value
$318.10
FCF Yield
3.4%
Div Yield
1.0%
Margins & Returns
Gross Margin
63.5%
Operating Margin
22.4%
Net Margin
12.9%
ROE
15.0%
ROA
14.2%
ROIC
10.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $7.17B | 65.2% | $1.96B | $849.0M | $2.20 | $1.72 |
| FY 2025 | $25.12B | 64.0% | $4.89B | $3.25B | $8.40 | $4.24 |
| Q3 2025 | $6.06B | 63.6% | $1.14B | $859.0M | $2.22 | $1.68 |
| Q2 2025 | $6.02B | 62.3% | $1.36B | $884.0M | $2.29 | $1.68 |
| Q1 2025 | $5.87B | 62.7% | $1.18B | $654.0M | $1.69 | $1.68 |
| Q4 2024 | $6.44B | 62.0% | $1.66B | $546.0M | $1.41 | $1.64 |
| FY 2024 | $22.59B | 61.9% | $5.06B | $2.99B | $7.76 | $4.04 |
| Q3 2024 | $5.49B | 61.8% | $1.21B | $834.0M | $2.16 | $1.60 |
| Q2 2024 | $5.42B | 61.3% | $1.16B | $825.0M | $2.14 | $1.60 |
| Q1 2024 | $5.24B | 60.9% | $1.00B | $788.0M | $2.05 | $1.60 |
| Q4 2023 | $5.82B | 61.1% | $1.43B | $1.14B | $2.98 | $1.55 |
| FY 2023 | $20.50B | 61.0% | $4.28B | $3.17B | $8.25 | $3.80 |